fig5

 <i>ROS1</i> mutations promote an immunosuppressive tumor microenvironment via <i>MYC</i> to confer immune evasion in head and neck cancer

Figure 5. GSEA results for hallmark gene sets (A) and KEGG pathways (B-D). A t-value > 0 (red) indicates higher scores in ROS1-Mut tumors; t-value < 0 (blue) indicates higher scores in ROS1-WT tumors. GSEA: Gene set enrichment analysis; ROS1-Mut: ROS1 mutations; ROS1-WT: ROS1-wild-type.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/